The effect of 8 weeks versus 12 weeks steroid therapy on serum 25-hydroxy vitamin D level in children with nephrotic syndrome during remission phase
Phase 2
- Conditions
- ephrotic syndrome.Nephrotic syndrome
- Registration Number
- IRCT201404269014N33
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
(a) age of 1-18 years; (b) affected with nephrotic syndrome; (c) being in remission phase.
Exclusion criteria: (a) children with malnutrition; (b) receiving vitamin D supplement during the last three months; (c) having liver, pancreatic, or gastrointestinal diseases; (d) using phenytoin, phenobarbital, isoniazid, or rifampin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The serum 25-hydroxy vitamin D level. Timepoint: at the end of treatment. Method of measurement: through taking blood sample.
- Secondary Outcome Measures
Name Time Method Measuring the relapse of nephrotic syndrome. Timepoint: at the end of treatment. Method of measurement: through taking urine sample and measuring proteinuria equal to or greater than 2 plus.